Yoshino Yutaro, Miyagi Jun, Toume Reo, Naha Yui, Uchihara Teruhito, Akamine Morikazu, Nakazato Hidetsugu, Kawakami Masayo, Tomori Takehiko, Nagayoshi Seiji, Nagamine Shinji, Tomiyama Takeshi, Ohmine Yasushi, Sasaki Hideaki, Ishikawa Masashi, Maeshiro Kanetaka
Dept. of Respiratory Surgery, Okinawa Red Cross Hospital.
Gan To Kagaku Ryoho. 2019 Jul;46(7):1171-1173.
Case 1: 83 years old man. For left upper lobe lungs squamous cell carcinoma infiltrating left main pulmonary artery. After 2 courses went of carboplatin(CBDCA)(AUC: 6)+weekly nab-paclitaxel(nab-PTX)(AUC: 6)+, left upper lobectomy and ND2 lymph nodes dissection. Tumor disappeared in pathology and diagnosed of Ef. 3. Case 2: 81 years old man. Right upper lobe lungs squamous cell carcinoma in #4R lymph node metastasis with the superior vena cava invasion. After 2 courses went of CBDCA(AUC: 6)+weekly nab-PTX(100mg/m2), left upper lobectomy and ND2 lymph nodes dissection. Tumor disappeared in pathology and diagnosed of Ef. 3. Nab-PTX may be considered a preoperative chemotherapeutic agent of choice for squamous cell carcinoma.
